Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PDA for Kidneys Study

NCT: NCT06658496 · RECRUITING

NCT IDNCT06658496
StatusRECRUITING
Start Date2024-12-19
Completion2027-05

Brief Summary

The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.

Frequently Asked Questions

What is PDA for Kidneys Study?

PDA for Kidneys Study is a clinical trial registered under NCT06658496. Current status: RECRUITING.

What is the status of NCT06658496?

The current status of NCT06658496 (PDA for Kidneys Study) is: RECRUITING.

When did PDA for Kidneys Study start?

PDA for Kidneys Study started on 2024-12-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.